Different optimal injection sites (TB-500 anywhere, BPC-157 near injury)
This anti-inflammatory activity occurs without apparent immunosuppression, suggesting selective modulation of inflammatory pathways rather than global immune suppression
Research demonstrates BPC-157 increases mesenchymal cell recruitment with periosteum reactivation occurring within 3 days of treatment initiation, establishing conditions favorable for rapid bone repair
Side Effects Injection Site Reactions : Pain, redness, or itching at the injection site are typical adverse effects
Dual therapy is not appropriate for all patients and is determined on a case-by-case basis by your Rivas provider
These bacteria switch to producing porphyrins, the researchers explained, and in some people, this uptick in inflammatory compounds may contribute to acne